Ladybug Resource Group (LBRG) Fair Value & Analysis

Healthcare · US · Market cap $2.0M

A solid business, screening 202% undervalued on our models.

What matters now

• The price is below even our cautious bear case ($0.0083). The market is more pessimistic than our downside scenario.
• The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
• Solid quality (54/100) at a price below fair value, the discount is the argument here, not the business quality.
• The models converge in a tight band ($0.0083 to $0.0091), unusually little disagreement for a valuation.

Price vs Fair Value (5 years)

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.

How to read this chart

60‑month range $0.0001 – $0.0900 · fair‑value band $0.0083 – $0.0091 · the $0.0030 price screens below the $0.0091 fair value. Dashed = 300-day average. As of Jul 31, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Ladybug Resource Group (LBRG) currently trades at $0.0030, while our model-based Fair Value estimate is $0.0091, implying the stock looks roughly 202.1% undervalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.

Trailing-twelve-month revenue stands at $6.3K. Fundamentals as of Jul 31, 2026

Our scenario range runs from $0.0083 (bear case) to $0.0091 (bull case); at $0.0030, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -15% fair-value upside, at 202%, LBRG screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Widest divergence: Multiples ($0.0200) versus Earnings-Based ($0.0100). Highest evidence: ROIC Compounder (72).

Key figures & financial health

Quality Score breakdown

About the company

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area.

Full company description

Ladybug Resource Group, Inc. designs the message or marketing theme included on Internet Websites, primarily focusing on the Websites of the funeral industry in the Seattle, Washington area. The company is also developing Solar Tracer, a solar collector that would use concentrating solar power technology to capture energy from the sun and transfer it in the form of heat to run steam turbine generators. In addition, it offers health supplements for men and women that help with issues, such as sleeplessness, headaches, aches and pains, mood improvement, energy, calm support, and appetite control; athletic supplements to enhance and sustain athletic performance; and nutritional supplement products. The company intends to sell its health products and formulas through wholesale channels; or license products to other manufacturers or multi-level marketing organizations. Ladybug Resource Group was founded in 2007 and is based in Kirkland, Washington.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2014 – FY2024 · reported fiscal years

Ladybug Resource Group reported revenue of $1.2M in FY2024 versus $41.6K in FY2014, a compound +39.9%/yr. Reported net income was −$20.5K in FY2024.

Watch LBRG: get an alert when its fair value changes →

Peer Group

Pharmaceutical Retailers · 61 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).

Explore undervalued stocks

More undervalued Healthcare stocks →

Frequently asked questions

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.